Impact of a transition program with navigator on loss to follow-up, medication adherence, and appointment attendance in hemoglobinopathies.
Brooke AllemangKate AllanColleen JohnsonMelina CheongPatrina CheungIsaac OdameRichard WardSuzan WilliamsGeetha MukerjiKevin H M KuoPublished in: Pediatric blood & cancer (2019)
A transition program with TN significantly reduced loss to follow-up, and significantly improved and maintained fair to good medication adherence. Further analysis of economic benefit and patient satisfaction will be conducted.
Keyphrases